Department of Woman and Child Health Sciences, Child Health Area, University Hospital Agostino Gemelli, Rome, Italy.
Neonatal Intensive Care Unit, "San Giovanni Calibita Fatebenefratelli" Hospital, Rome, Italy.
Pediatr Pulmonol. 2022 Sep;57(9):2227-2236. doi: 10.1002/ppul.26031. Epub 2022 Jun 20.
To propose an early lung ultrasound (LUS) score for the prediction of the need for respiratory assistance in newborns of gestational age (GA) ≥ 33 weeks presenting respiratory distress.
Multicenter, prospective observational study in third-level neonatal intensive care units.
Infants with GA ≥ 33 + 0 weeks with respiratory distress within 3 h of life.
Three LUS for each patient were collected: within 3 h of life (T0), at 4-6 h of life (T1), and at the resolution of symptoms (T2). The primary aim was to assess the validity of the early LUS score in predicting the need for continuous positive airway pressure (CPAP). We also evaluated the validity of the score in predicting the need for surfactant, the scores' trend in our population, and any correlation with the duration of ventilation and oxygen therapy.
Sixty-two patients were enrolled in the study. The mean GA was 36 weeks. The receiver operating characteristic analysis for the LUS T0 and T1 yielded area under the curves of 0.91 and 0.82 in predicting the need for CPAP, respectively. LUS score cut off of 6 (sensitivity 84.8%, specificity 86.2%) and 5 (sensitivity 66.7%, specificity 100%) were calculated at T0 and T1, respectively. We found significant correlations between LUS score and respiratory assistance, surfactant administration, and SpO /FiO ratio.
An early LUS score is a good noninvasive predictor of the need for respiratory assistance with CPAP and surfactant administration in newborns with GA ≥ 33 weeks.
提出一种早期肺部超声(LUS)评分,用于预测胎龄(GA)≥33 周且有呼吸窘迫的新生儿需要呼吸支持。
多中心、前瞻性观察性研究,在三级新生儿重症监护病房进行。
GA≥33+0 周、出生后 3 小时内有呼吸窘迫的婴儿。
为每位患者采集 3 次 LUS:出生后 3 小时内(T0)、出生后 4-6 小时(T1)和症状缓解时(T2)。主要目的是评估早期 LUS 评分预测持续气道正压通气(CPAP)需求的有效性。我们还评估了评分预测表面活性物质需求的有效性、评分在我们人群中的趋势以及与通气和氧疗时间的任何相关性。
研究共纳入 62 例患者。平均 GA 为 36 周。LUS T0 和 T1 的受试者工作特征曲线分析分别预测 CPAP 需求的曲线下面积为 0.91 和 0.82。在 T0 和 T1 时,LUS 评分分别为 6(敏感性 84.8%,特异性 86.2%)和 5(敏感性 66.7%,特异性 100%)时,可预测 CPAP 和表面活性物质的需求。我们发现 LUS 评分与呼吸支持、表面活性物质应用和 SpO/FiO 比值之间存在显著相关性。
早期 LUS 评分是预测胎龄≥33 周且有呼吸窘迫的新生儿需要 CPAP 和表面活性物质治疗的一种良好的非侵入性预测指标。